Literature DB >> 35762465

How real can we get in generating real world evidence? Exploring the opportunities of routinely collected administrative data for evaluation of medical devices.

Benedetta Pongiglione1, Aleksandra Torbica1.   

Abstract

Real-world data are considered a potentially valuable source of evidence for assessing medical technologies in clinical practice, but their widespread use is hampered by numerous challenges. Using the case of coronary stents in Italy, we investigate the potential of administrative databases for estimating costs and health outcomes associated with the use of medical devices in real world conditions. An administrative dataset was created ad hoc by merging hospital records from patients admitted between 2013 and 2019 for stent implantations with ambulatory records, pharmaceutical use data and vital statistics. Health outcomes were multifold: all-cause and cardiac mortality and myocardial infarction, within 30 days, 1, 2, 5 years. Costs were estimated from the National Health System perspective. We used multivariable Cox models and propensity score (PS) methods (PS matching; stratification on PS; inverse probability of treatment weighting using PS; PS adjustment). 257,907 coronary stents were implanted in 113,912 patients. For all health outcomes and follow-up times, and across all methods, patients receiving drug-eluting stents (DES) presented lower risk. For all-cause mortality, the DES patient advantage over bare-metal stent (BMS) patients declined over time but remained significant even at 5 years. For myocardial infarction, results remained quite stable. The DES group presented lower cumulative total costs (ranging from 3264 to 2363 Euros less depending on methods). Our results confirm the consolidated evidence of the benefits of DES compared to BMS. The consistency of results across methods suggests internal validity of the study, while highlighting strengths and limitations of each depending on research context. Administrative data yield great potential to perform comparative effectiveness and cost-effectiveness analysis of medical devices provided certain conditions are met.
© 2022 The Authors. Health Economics published by John Wiley & Sons Ltd.

Entities:  

Keywords:  administrative data; medical device; propensity score; real-world data; real-world evidence

Mesh:

Year:  2022        PMID: 35762465     DOI: 10.1002/hec.4562

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   2.395


  1 in total

1.  Coverage with evidence development for medical devices in Europe: Can practice meet theory?

Authors:  Michael Drummond; Carlo Federici; Vivian Reckers-Droog; Aleksandra Torbica; Carl Rudolf Blankart; Oriana Ciani; Zoltán Kaló; Sándor Kovács; Werner Brouwer
Journal:  Health Econ       Date:  2022-02-26       Impact factor: 2.395

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.